Virtual Path Planning for Image-guided Needle Interventions

N/ACompletedNCT02021071

Philips Clinical & Medical Affairs Global24 enrolled

Overview

Philips Healthcare has added a virtual path planner to the current commercially available XperGuide software platform and that has the potential to significantly reduce dose during image-guided needle interventions.

The investigational device is used for image guidance by virtually planned path and X-ray data.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Gastrointestinal Diseases Bone Diseases Muscular Diseases Spinal Diseases Vascular Diseases

Interventions

XperGuideRADIATION

Live 3D image needle guidance which overlays live fluoroscopy and 3D soft tissue imaging data from previous acquired CT, MR or XperCT.

XperGuide with virtual path planningRADIATION

Instrument guidance allowing certain tasks that would normally occur using continuous X-ray guidance to be performed with reduced dose for patient and staff.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients at any age who are referred for a clinically indicated XperGuide interventional procedure. * The informed consent has been signed by the participant, parent or legal guardian as appropriate. Exclusion Criteria: -Pregnant patients.

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Outcomes

Primary Outcomes

System Usability Scale (SUS) Score as a Measure of Qualitative Clinical Usefulness

Evaluate the workflow, usability, and clinical impact of device by assessing clinical outcome and success of the procedures. The SUS is a simple, ten-item attitude Likert scale giving a global view of subjective assessments of usability developed by Brooke, J. The user needs to provide agreement or disagreement for the 10 statements. After the appearing of the SUS in literature and once part of the ISO standard ISO 9241 Part 11 it has become an industry standard and has been used for over 25 years to measure usability. The minimum score is 0 and the maximum core is 100. Analysis of 500 studies with SUS showed that the average SUS score is a 68. A SUS score above a 68 would be considered above average and anything below 68 is below average

Time frame: Patients will be followed starting from the procedure until hospital discharge or until 2 weeks after date of procedure at the latest

Secondary Outcomes

Fluoroscopy Time

Measure fluoroscopy time (minutes) needed during needle interventional procedure and compare the collected results with existing data from needle interventional procedures performed using XperGuide alone.

Time frame: Patients will be followed starting from the procedure until hospital discharge or until 2 weeks after date of procedure at the latest

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.